Sertoli-Leydig cell tumor in a patient with hyperandrogenism: New approaches to diagnosis
https://doi.org/10.62751/2713-0177-2026-7-1-12
Abstract
The article presents a clinical case of a 55-year-old woman who was diagnosed with hyperplasia of the medial pedicle of the left adrenal gland and the formation of the left ovary against the background of pronounced manifestations of hyperandrogenism syndrome: androgen-dependent alopecia, hirsutism, arterial hypertension, fasting and postprandial hyperglycemia. Hyperandrogenism was confirmed by laboratory tests, the hormonal activity of the left adrenal hyperplasia was excluded. Using gas chromatography-mass spectrometry of daily urine and selective blood sampling from the ovarian veins with an assessment of the concentration of androstenedione and testosterone, the ovarian origin of hyperandrogenism syndrome was proved. The patient underwent laparoscopic extirpation of the uterus and appendages, followed by regression of symptoms. The normalization of hormones was biochemically confirmed after 3 months. The clinical case demonstrates the high sensitivity and specificity of gas chromatography-mass spectrometry, highlighting the importance of this method for the differential diagnosis of adrenal and gonadal diseases.
Keywords
About the Authors
K. D. MusevichRussian Federation
Ksenia D. Musevich
195253; Marshal Tukhachevsky St., 23, building 1, apt. 570; Saint Petersburg
N. V. Vorokhobina
Russian Federation
Natalia V. Vorokhobina, Dr. Sci. (Med.), professor
Saint Petersburg
Z. R. Shafigullina
Russian Federation
Zulfiya R. Shafigullina, Cand. Sci. (Med.)
Saint Petersburg
V. L. Baranov
Russian Federation
Vitalii L. Baranov, Dr. Sci. (Med.), professor
Saint Petersburg
T. V. Eremenko
Russian Federation
Tatyana V. Eremenko, Cand. Sci. (Med.). associate professor
Saint Petersburg
M. A. Khassaan
Russian Federation
Marina A. Khassaan
Saint Petersburg
D. V. Bogaevskaia
Russian Federation
Diana V. Bogaevskaia
Saint Petersburg
Yu. V. Kovalyova
Russian Federation
Yuliya V. Kovalyova, Cand. Sci. (Med.), associate professor
Saint Petersburg
References
1. Moran C, Arriaga M, Rodriguez G, Moran S. Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol. 2012;2012:317241. doi: 10.1155/2012/317241
2. Unanian AL, Arakelov S, Polonskaia LS, Guriev TD, Kossovich IuM, Baburin DV. Hyperandrogenism: The pathogenesis, diagnosis, and therapy (a clinical lecture). Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2014;14(2):101–106 (In Russ.) doi: 10.21886/2219-8075-2022-13-3-107-117
3. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(6):2760–66. doi: 10.1210/jc.2002-021875
4. Vorokhobina NV, Velikanova LI, Glavnova OB, Malevanaya EV, Galakhova RI, Matezius IV. Metabolomics of androgens, progestins and glucocorticoids in women with polycystic ovary syndrome according to gas chromatography-mass spectrometry. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women's Diseases. 2020;69(5):27–38 (In Russ.) doi: 10.17816/JOWD69527-38
5. Goodarzi MO, Carmina E, Azziz R. DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol. 2015;145:213–25. doi: 10.1016/j.jsbmb.2014.06.003
6. Clinical guidelines. Congenital adrenal hyperplasia (adrenogenital syndrome). Russian Association of Endocrinologists, Russian Society of Obstetricians-Gynecologists. Rubricator of clinical guidelines of the Ministry of Health of the Russian Federation. 2025. ID: 82_3. URL: https://cr.minzdrav.gov.ru/view-cr/82_3 (date of access – 12. 12. 2025) (In Russ.)
7. Clinical guidelines. Nonepithelial ovarian tumors. Association of Oncologists of Russia, Russian Society of Clinical Oncology, Russian Society of Specialists in Prevention and Treatment of Reproductive System Tumors. Rubricator of clinical guidelines of the Ministry of Health of the Russian Federation. 2024. ID: 541_2. URL: https://cr.minzdrav.gov.ru/view-cr/541_2 (date of access – 12. 12. 2025) (In Russ.)
8. Yadav V, Sharma Y. Hyperandrogenism. Indian J Pediatr. 2023;90(10):1018–24. doi: 10.1007/s12098-023-04678-7
9. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2–6. doi: 10.1210/jc.2005-1457
10. LeVee A, Suppogu N, Walsh C, Sacks W, Simon J, Shufelt C. The masquerading, masculinizing tumor: A case report and review of the literature. J Womens Health (Larchmt). 2021;30(7):1047–51. doi: 10.1089/jwh.2020.8548
11. Buzinskiene D, Marciukaityte R, Sidlovska E, Rudaitis V. Ovarian Leydig cell tumor and ovarian hyperthecosis in a postmenopausal woman : A case report and literature review. Medicina (Kaunas). 2023;59(6):1097. doi: 10.3390/medicina59061097
12. Pavlovich SV, Yurova MV, Chagovets VV, Frankevich VE, Starodubtseva NL, Chuprynin VD, Sukhikh GT. Features of blood steroid hormone profiles in reproductive age patients with advanced endometriosis. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2021;(3):90–100 (In Russ.) doi: 10.18565/aig.2021.3.90-100
13. Matyushenko MV, Vorokhobina NV, Velikanova LI, Kovaleva YuV. Urinary steroid metabolomics in women with different phenotypes of polycystic ovary syndrome according to gas chromatography-mass spectrometry. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women's Diseases. 2018;67(3):30–37 (In Russ.) doi: 10.17816/JOWD67330-37
14. Sharma A, Welt CK. Practical approach to hyperandrogenism in women. Med Clin North Am. 2021;105(6):1099–116. doi: 10.1016/j.mcna.2021.06.008
15. Glavnova OB, Vorokhobina NV, Velikanova LI, Yarmolinskaya MI, Malevanaya EV, Strelnikova EG, Balandina KA. Gas chromatography-mass spectrometry based steroid metabolomics in women with different phenotypes of polycystic ovarian syndrome and normal body weight. Meditsinskiy vestnik Yuga Rossii = Medical Herald of the South of Russia. 2022;13(3):107–117 (In Russ.) doi: 10.21886/2219-8075-2022-13-3-107-117
16. Kaltsas GA, Mukherjee JJ, Kola B, Isidori AM, Hanson JA, Dacie JE, et al. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clin Endocrinol (Oxf). 2003;59(1):34–43. doi: 10.1046/j.1365-2265.2003.01792.x
Review
For citations:
Musevich K.D., Vorokhobina N.V., Shafigullina Z.R., Baranov V.L., Eremenko T.V., Khassaan M.A., Bogaevskaia D.V., Kovalyova Yu.V. Sertoli-Leydig cell tumor in a patient with hyperandrogenism: New approaches to diagnosis. FOCUS. Endocrinology. 2026;7(1):95-100. (In Russ.) https://doi.org/10.62751/2713-0177-2026-7-1-12
JATS XML














